Adjunctive Sedation With Dexmedetomidine for the Prevention of Severe Inflammation and Septic Encephalopathy

Clinical trial NCT04076826 · COMPLETED

Trial details

NCT number: NCT04076826
Sponsor: Insel Gruppe AG, University Hospital Bern
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Sepsis-Associated Encephalopathy

Start date: 2019-09-01
Primary completion: 2022-06-17
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.